COVID-19 Research Paper Volume 13, Issue 7 pp 9265—9276
Differentially expressed immune response genes in COVID-19 patients based on disease severity
Figure 4. Expression levels of other COVID-19-related genes in patients with varying degrees of disease severity. (A) ACE2 (P=0.0057 for MM vs Neg; P=0.0313 for SC vs Neg), (B) IFNγ (P=0.0095 for MM vs Neg; P=0.0091 for SC vs Neg), (C) PD1 (P=0.0248 for MM vs Neg; P=0.0353 for SC vs Neg), (D) IDO1 (P<0.0001 for MM vs Neg; P=0.0052 for SC vs MM), (E) miR-155 (P<0.0001 for MM vs Neg; P<0.0001 for SC vs MM), (F) miR-130a (P<0.0001 for MM vs Neg; P<0.0001 for SC vs MM). *P<0.05, **P<0.01, ***P<0.001.